Study Evaluating Venlafaxine ER in Adults With Panic Disorder

The primary objective of this study is to determine the efficacy, safety, and tolerability of a flexible dose of venlafaxine extended-release (ER) capsules administered for 10 weeks in the treatment of adult outpatients with panic disorder (PD) in a placebo-controlled phase III study.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Panic Disorder Anxiety Disorders Disease Mental Disorders Pathologic Processes Pathological Conditions, Signs and Symptoms

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 3

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

A male or female outpatient
Be at least 18 years of age and legal age of consent
Meet DSM-IV criteria for PD (with or without agoraphobia) for at least 3 months before study day 1

Exclusion criteria

Treatment with venlafaxine (IR or ER) within 6 months of study day 1
Known hypersensitivity to venlafaxine (IR or ER) or related compounds
History or presence of any clinically important hepatic, renal, or other medical disease that might compromise the study or be detrimental to the patient (eg, clinically important cardiac arrhythmia, unstable diabetes, carcinoma [except basal cell epithelioma], uncontrolled hypertension)

Treatment and study plan

Venlafaxine ER

Drug

Sponsors and collaborators

Lead sponsor

Wyeth is now a wholly owned subsidiary of Pfizer

Industry

Registry information

Official study title

A Double-blind, Placebo-controlled, Parallel-group, Flexible-dose Study of Venlafaxine Extended-release Capsules in Adult Outpatients With Panic Disorder

Important dates

Study start: 2001
Primary completion: 2002
Study completion: 2002
First posted: Jun 7, 2002
Registry last updated: Aug 14, 2009

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed